Keyphrases
50th Percentile
8%
Alphabet Knowledge
9%
Angiogenesis
19%
Angiogenic Property
19%
Aspirin
11%
Biological Processes
7%
Birth Weight
8%
Cancer Effects
19%
Cell-free RNA
19%
Chemoresistance
19%
Chilean
24%
Circulating Levels
19%
Clinical Application
19%
Confidence Interval
19%
Diagnostic Performance
19%
Differentially Expressed
5%
Direct Quantification
19%
During Pregnancy
44%
Early childhood
19%
Early Detection
7%
Early Markers
19%
Earthquake
18%
Earthquake Effects
19%
Endometrial Stem Cells
39%
Extracellular Vesicles
29%
Fetal Development
6%
Fetus
23%
First Trimester
22%
First-trimester Screening
19%
Forkhead Box M1 (FOXM1)
19%
Gestational Age
8%
Gestational Age at Birth
8%
Gestational Diabetes
19%
Gestational Diabetes Mellitus
7%
Head Circumference
19%
High Risk
8%
High-magnitude Earthquake
19%
History of Preeclampsia
39%
IASPP
19%
In Silico Analysis
5%
Large Mammals
19%
Late-onset Preeclampsia
5%
Maternal Exposure
19%
Maternal Plasma
25%
Maternal Risk Factors
19%
Maternal Stress during Pregnancy
19%
Menses
19%
Menstrual Blood
21%
Menstrual Period
8%
Mesenchymal Stem Cells
19%
Meta-analysis
19%
Mitotic Catastrophe
19%
Natural Disasters
8%
Non-coding RNA (ncRNA)
39%
Normality
19%
Novel Biomarkers
19%
Nulliparous Women
6%
Omega-3
19%
Omega-3 Supplements
19%
Ovarian Cancer
19%
Paclitaxel
19%
Patients at Risk
7%
Perinatal Outcome
19%
Placebo
9%
Placenta
40%
Placental Dysfunction
9%
Predictive Screening
19%
Preeclampsia
100%
Preeclamptic
7%
Pregnancy Trimester
29%
Pregnant Women
19%
Prenatal Stress
8%
Preterm Birth
19%
Preterm Birth Risk
19%
Previous History
19%
Print Knowledge
9%
Quantitative PCR
5%
Readability
19%
Register Study
19%
Reproductive Life
19%
RNA Assay
19%
Santiago De Chile
6%
Second Trimester
10%
Selective Intrauterine Growth Restriction (sIUGR)
21%
Small Extracellular Vesicles
19%
Small Head
8%
Spontaneous Preterm Birth (sPTB)
19%
Stressful Events
9%
Systematic Meta-analysis
19%
Third Trimester
6%
Tissue Plasminogen Activator (t-PA)
19%
Trimester
14%
Trophoblast
19%
Trophoblast Invasion
21%
Trophoblast Migration
19%
Uterine Artery Pulsatility Index
19%
Vaginal Cup
19%
Vaginal Delivery
8%
Volume of Fluid
19%
Week of Gestation
7%
Medicine and Dentistry
Acetylsalicylic Acid
7%
Angiogenesis
19%
Biological Marker
15%
Birth Weight
9%
Cancer Cell
6%
Carcinogenesis
6%
Case-Control Study
5%
Cell Line
6%
Clinical Trial
9%
Diagnostic Performance
19%
Disease
20%
Downregulation
6%
Drug Resistance
19%
Family Planning
9%
First Trimester Pregnancy
63%
Gene Amplification
6%
Gestational Age
25%
Gestational Diabetes
19%
Human Umbilical Vein Endothelial Cell
13%
In Vitro
10%
Intrauterine Growth Retardation
19%
Invasive Carcinoma
6%
Linear Regression Analysis
9%
Long Untranslated RNA
19%
Maternal Plasma
19%
Maternal Risk Factor
19%
Menstrual Cycle
19%
Menstruation
19%
Mesenchymal Stem Cell
19%
Messenger RNA
24%
Neonatal Infant
19%
Nulliparous
14%
Ovarian Cancer
19%
Paclitaxel
19%
Placenta
18%
Placenta Development
10%
Pre-Eclampsia
99%
Pregnancy
13%
Programmed Cell Death
9%
Protein P53
13%
Pulsatility Index
19%
Real-Time Polymerase Chain Reaction
10%
Regulator Protein
6%
Second Trimester Pregnancy
13%
Separase
9%
Small Interfering RNA
13%
Spontaneous Abortion
19%
Stem Cell
19%
Third Trimester Pregnancy
8%
Tissue Plasminogen Activator
19%
Trophoblast
59%
Upregulation
6%
Uterine Artery
19%
Vaginal Delivery
9%
Vasculotropin
8%
Biochemistry, Genetics and Molecular Biology
Adiponectin
9%
Angiogenesis
19%
Birth Weight
19%
Blood Plasma
33%
Carcinogenesis
6%
Case-Control Study
8%
Coculture
6%
Decidualization
6%
Downregulation and Upregulation
6%
First Trimester Pregnancy
53%
Induced Stem Cells
19%
Leptin
9%
Long Non-Coding RNA
19%
Low Birth Weight
9%
Maternal Age
9%
Maternal Stress
29%
Messenger RNA
19%
Oxygen Tension
6%
Placenta Development
11%
Population Research
9%
Pregnancy
25%
Progeny
11%
Real-Time Polymerase Chain Reaction
6%
Second Trimester Pregnancy
23%
Small Extracellular Vesicles
19%
Small Interfering RNA
13%
Stem Cell
26%
Stromal Cell
5%
Third Trimester Pregnancy
13%
Tissue Plasminogen Activator
19%
Trophoblast
39%
Vascular Endothelial Growth Factor
8%